Monday, February 27, 2012
|
On Thursday, February 23, 2012, more than 60 guests gathered at the iconic Breakers hotel in Palm Beach, Florida to enjoy an evening with the University of Maryland School of Medicine’s Dr. William Regine, The Isadore and Fannie Schneider Foxman Chair and Professor of Radiation Oncology, and Dr. Mohan Suntha, The Marlene and Stewart Greenebaum Professor and Vice Chairman of Radiation Oncology. Drs. Regine and Suntha delivered a short presentation entitled “Redefining the Paradigm for Cancer Care: The future of the University of Maryland Department of Radiation Oncology at the University of Maryland Marlene and Stewart Greenebaum Cancer Center.” Mr. Stuart Weitzman, Chairman of the Greenebaum Cancer Center Board of Advisors, also made brief remarks.
This event, presented by the Office of Development, is the first in a series of receptions that provide guests with the opportunity to interact one-on-one with esteemed faculty members at the School of Medicine, whose innovative work is advancing the face of medicine. Guests included patients and friends of the Cancer Center and alumni of the University of Maryland School of Medicine. Dr. Regine gave special recognition to one of the only living members of the Class of 1935, Dr. Harold W. Rosenberg, who will turn 100 years old in March 2012.
Dr. Regine spoke about the department’s Gammapod System, designed to eliminate the traditional surgery and radiation treatment ordeal for women with early-stage breast cancer. Gammapod was invented by Dr. Cedric Yu, the Carl M. Mansfield, MD, Endowed Professor in Radiation Oncology. Dr. Regine also highlighted the patient-focused care programs developed by the Department of Radiation Oncology, including theMagic Castle and Concierge programs.
Dr. Suntha introduced the $230 million Proton Therapy Center at the University of Maryland. Scheduled to open in 2014, it will offer the most advanced radiation technology in life-saving cancer treatment.
Dr. Regine has explained Proton Therapy as “the next-generation improvement in radiation oncology. It allows us the unprecedented ability to deliver a targeted dose of lifesaving radiation therapy directly to the tumor while minimizing radiation to the healthy tissue. It can result in more effective treatment for patients and fewer side effects. This technology is a powerful new addition to our tool box for fighting cancer.”

|
|
|